ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study
December 25, 2019The first part of the study, in which the effect of food intake on the uptake of KL1333 after a single dose had been assessed in healthy volunteers, showed promising drug properties and safety data. In the second part of the study, five cohorts of healthy
Pharma Sources Insight January 2025
